Estimating the Costs of Preventive Interventions

Foster, E. Michael; Porter, Michele M.; Ayers, Tim; Kaplan, David; Sandler, Irwin N.

doi:10.1177/0193841x07299247

Cited by 34 publications

(51 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Four types of costs have been identified as important in analysing the costs of preventive interventions such as bereavement programs (Foster, Porter, Ayers, Kaplan, & Sandler, 2007). These are medical, nonmedical, productivity, and intangible costs.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The Emotional and Economic Costs of Bereavement in Health Care Settings

Genevro¹,

Miller

2010

PSYCHOL BELG

View full text Add to dashboard Cite

Research to date on grief and bereavement in health care providers has focused on those experiences from the perspective of the individual. We propose, however, that the emotional costs of bereavement in the health care setting are also health care systems issues. This paper focuses on the emotional costs of grief and bereavement in health care providers, and on the economic costs of bereavement and bereavement care in health care settings. Evidence regarding the costs and cost-effectiveness of bereavement interventions is limited. We summarise existing relevant research and offer an overview of the types of costs and cost information that would optimally be collected in research on bereavement in health care settings. We also propose an analytic framework that could be used to systematically consider the larger picture of bereavement in health care settings, how available evidence fits into this picture, and what evidence is needed to improve care. This approach is derived from health services research. It is hoped that the proposed framework will prove useful in stimulating new research questions, and in guiding research that not only advances our understanding of the emotional and economic costs of bereavement but also improves bereavement care.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Estimates of productivity costs also may include the loss of capacity to perform tasks at home. Intangible costs are costs that are nonmonetary, such as stigma or loss of professional satisfaction, and are often extremely difficult to measure (e.g., Foster et al, 2007;Onrust et al, 2008).…”

Section: Resultsmentioning

confidence: 99%

The Emotional and Economic Costs of Bereavement in Health Care Settings

Genevro¹,

Miller

2010

PSYCHOL BELG

View full text Add to dashboard Cite

show abstract

“…ICERs that consider the same outcome can be used to compare the same Importantly, they answer common questions posed by policy makers and budget writers [22,64]. Further, by undertaking these analyses, researchers can provide decision makers with accurate estimates as opposed to back-of-the-envelope analyses that may consider only tangible resources but neglect crucial personnel, volunteer, and in-kind resources [65]. Both cost and costeffectiveness analyses have limitations in their utility for informing decision makers.…”

Section: Economic Evaluationmentioning

confidence: 99%

Financing prevention: opportunities for economic analysis across the translational research cycle

Crowley

Jones

2015

Behav. Med. Pract. Policy Res.

View full text Add to dashboard Cite

Prevention advocates often make the case that preventive intervention not only improves public health and welfare but also can save public resources. Increasingly, evidence-based policy efforts considering prevention are focusing on how programs can save taxpayer resources from reduced burden on health, criminal justice, and social service systems. Evidence of prevention's return has begun to draw substantial investments from the public and private sector. Yet, translating prevention effectiveness into economic impact requires specific economic analyses to be employed across the stages of translational research. This work discusses the role of economic analysis in prevention science and presents key translational research opportunities to meet growing demand for estimates of prevention's economic and fiscal impact.

show abstract

“…7 Cost analyses of health care interventions are essential in today's ever-changing health care field to ensure quality care while health care costs continue to increase annually. 8,9 Therefore, the authors of this article propose that home delivery of chemotherapy is an example of a PC intervention that can improve the QOL of pediatric oncology patients, foster a cost savings plan, and also support the WHO definition of PC.…”

mentioning

confidence: 99%

“…Also, in several studies, investigators have reported that a major benefit of outpatient delivery of chemotherapy results in significant reduced health care costs (ie, due to decreased hospital admissions). 8,9,[11][12][13] Standard risk medulloblastoma (SRMB) patients spend approximately 14 months after diagnosis undergoing radiation and chemotherapy. Because survival has improved to almost 90%, 14 it is imperative to focus not only on the QOL of survivors but also on the patient's QOL while receiving oncology treatments.…”

mentioning

confidence: 99%

Benefits of Using an Early Palliative Care Intervention in Pediatric Oncology

Madden

Vaughn

Northouse

et al. 2015

Journal of Hospice & Palliative Nursing

View full text Add to dashboard Cite

Early palliative care (PC) interventions can foster effective symptom management during oncology treatments. Children with cancer are an appropriate population to receive early PC interventions to minimize suffering and foster quality of life during oncology treatments. Delivery of cisplatin along with posthydration (PH) intravenous fluids (IVFs) is an example of an early PC intervention for children diagnosed with standard risk medulloblastoma. In this study, we performed a retrospective chart review to evaluate the impact of outpatient delivery of cisplatin and PH IVF on target outcomes (renal function, ototoxicity, and health care costs) for 45 pediatric patients with standard risk medulloblastoma. Evaluation of physical outcomes revealed (a) no significant changes in serum creatinine, (b) no signs of hemorrhagic cystitis or renal insufficiency, and (c) no significant increase in signs of ototoxicity. Evaluation of health care costs revealed a reduction in the number of required hospital admissions for pediatric patients receiving outpatient cisplatin and PH IVF. In summary, PH IVF after delivery of cisplatin seems to be a potentially effective early PC intervention that may benefit the pediatric oncology patient by preserving renal function, reducing the risk of ototoxicity, and reducing health care costs because of the decreased number of hospital admissions related to outpatient delivery of cisplatin treatments.

show abstract

Estimating the Costs of Preventive Interventions

Cited by 34 publications

References 17 publications

The Emotional and Economic Costs of Bereavement in Health Care Settings

The Emotional and Economic Costs of Bereavement in Health Care Settings

Financing prevention: opportunities for economic analysis across the translational research cycle

Benefits of Using an Early Palliative Care Intervention in Pediatric Oncology

Contact Info

Product

Resources

About